Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Xenograft
58%
Minimal Residual Disease
50%
Antibody-Drug Conjugate
50%
Cytoskeleton
50%
Leukemia Cell
50%
Small Cell Lung Cancer
50%
Magnetic Resonance Imaging
50%
Magnetic Resonance Imaging of Brain
50%
Percutaneous Coronary Intervention
50%
Glycoprotein
50%
Radiation Therapy
50%
Precursor
33%
B Cell
33%
Cell Line
25%
Dexamethasone
25%
Prevalence
25%
Radiographer
25%
Rare Disease
25%
Decision Making
25%
Oncologist
25%
Population
25%
Overall Survival
20%
In Vitro
16%
Combination Chemotherapy
16%
Diseases
10%
Brain Metastasis
10%
Immunotherapy
10%
Cancer Research
10%
Electrocorticography
10%
Intervention Trial
10%
Failure Free Survival
10%
Absence
10%
Diagnosis
8%
Cell Interaction
8%
Malignant Neoplasm
8%
Extracellular Space
8%
Leukemia Cell Line
8%
High Throughput Screening
8%
Engraftment
8%
Monotherapy
8%
Spontaneous Remission
8%
Biological Marker
8%
Interstitial Fluid
8%
Immunology and Microbiology
Mouse
66%
Xenograft
66%
Precursor
62%
B Cell
62%
Glycoprotein
50%
Cell Line
50%
Cytoskeleton
50%
Magnetic Resonance Imaging
50%
Antibody Drug Conjugate
50%
Leukemia Cell
50%
Dexamethasone
37%
CD19
16%
Cell Interaction
16%
High Throughput Screening
16%
Interstitial Fluid
16%
Extracellular Space
16%
Overall Survival
14%
Engraftment
12%
Dilution
12%
Leukemia Cell Line
12%
Immunotherapy
7%
Failure Free Survival
7%
Pharmacology, Toxicology and Pharmaceutical Science
Small Cell Lung Cancer
50%
Prevalence
50%
Rare Disease
50%
Overall Survival
20%
Epileptic Absence
10%
Immunotherapy
10%
Brain Metastasis
10%
Malignant Neoplasm
10%
Chemotherapy
10%
Intervention Trial
10%
Disease
10%
Failure Free Survival
10%
